Senzime AB (publ) (SNZZF OTCGREY) stock market data APIs
$0.6783
0(0%)
as of September 17, 2025
Try our APIs with
free plan!
Senzime AB (publ) Financial Data Overview
Price chart is built with
Anychart
Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The company offers TetraGraph, a quantitative neuromuscular transmission monitor, which supports neuromuscular blockade management from induction to recovery; and ExSpiron, a non-invasive monitoring system that uses bioelectrical impedance sensor to measure the tissue's opposition to carrying an alternating electrical current. It also provides additional products, including CliniSenz Analyzer and OnZurf Probe. The company has a strategic connectivity and licensing agreement with Masimo to develop, manufacture, market, and distribute products that can connect to the Masimo Root patient monitoring system; license agreement with Fukuda Denshi Co. Ltd. to license TetraGraph technology; and license agreement with CoreSpiron (Henan) Co Ltd. to manufacture and sell ExSpiron system. Senzime AB (publ) was incorporated in 1999 and is headquartered in Uppsala, Sweden.
Prev. Close
0.6783
Open
0.6783
High
0.6783
Low
0.6783
52 wk Range
0.3935-0.7359
Market Cap
106 M
Shares Outstanding
157 M
Revenue
80 635 K
EPS
-0.0354
Beta
0.509
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Senzime AB (publ) data using free add-ons & libraries
Get Senzime AB (publ) Fundamental Data
Senzime AB (publ) Fundamental data includes:
- Net Revenue: 80 635 K
- EBITDA: -117 516 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-08-26
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Senzime AB (publ) News
New
Senzime Expands US Sales Team and Signs Additional Distribution Agreements
UPPSALA, Sweden, June 24, 2020 /PRNewswire/ -- Senzime AB (publ) today announces that the company has initiated its Sales Ramp Up in the US to establish a direct sales force in key territories and tha...
Is Senzime AB (publ) (STO:SEZI) Trading At A 48% Discount?
Does the May share price for Senzime AB (publ) (STO:SEZI) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by taking the expected future cash flows and discounting t...
Companies Like Senzime (STO:SEZI) Are In A Position To Invest In Growth
We can readily understand why investors are attracted to unprofitable companies. By way of example, Senzime (STO:SEZI) has seen its share price rise 145% over the last year, delighting many shareholde...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
